Treat to target strategy in rheumatoid arthritis: real benefits.
نویسنده
چکیده
Treating rheumatoid arthritis (RA) with a goal or «Treat to target» strategy is a therapeutic proposal taken from cardiovascular and endocrine literature. It proposes that the therapeutic target in RA should be a state of remission, or an alternative goal could be a low disease activity. Rheumatologists should measure and register disease activity in every clinical visit and if the goal has not been reached, therapeutic adjustments should be made. Current evidence from clinical trials and a meta-analysis supports the notion that this strategy has important clinical benefits in patients with early RA when compared with routine care. It is also described that using protocolized treatment offers greater benefits. Recent data from Dutch cohorts is presented showing its successful implementation. A discussion is offered on the need of more studies in established RA.
منابع مشابه
A Case of Acute Myeloid Leukemia Caused by Low Dose Methotrexate Used to Treat a Rheumatoid Arthritis Patient
Methotrexate is an anti-rheumatic agent used as a first-line tretment for rheumatoid arthritis. Hematological malignancies like lymphoma or acute myeloid leukemia have been reported to be secondary to treatment with Methotrexate, but are very uncommon. We report here the first Moroccan case of RA patient on low dose MTX, who developed AML. We also reviewed all similar cases.
متن کاملThe roles of sex, Perceived Pain and illness Perceptions on Disease Activity in Rheumatoid Arthritis
Background: In the “treating to target” strategy to rheumatoid arthritis (RA) management, “cognitive” beyond “physical” measures allow a more comprehensive assessment. This study reports a predictive analysis of patient properties on Disease Activity, and the degree to which these predictions could be uniquely attributable to Illness perception (IP), pain, and sex differences. Methods: This cr...
متن کاملTreating to target in rheumatoid arthritis - challenges and opportunities.
The treat to target approach to managing therapy in rheumatoid arthritis was only just formally proposed in 2010, yet it is clearly here to stay. While the original recommendations were based on a limited set of published data, subsequent studies have explored the role of the treat to target approach in a variety of clinical settings and have confirmed its value. Despite this, additional data i...
متن کاملMonitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry.
OBJECTIVES Advances in aggressive use of conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) as well as biological DMARDs (bDMARDs) have improved the treatment armamentarium for rheumatologists, and modern treatment principles include a treat-to-target (T2T) strategy. However, little is known about the feasibility of a T2T strategy in patients with rheumatoid arthritis (RA)...
متن کاملOverview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission.
OBJECTIVES To present an updated overview of tight control studies with a fixed treatment target ('treat-to-target'), reporting on (sustained) remission in rheumatoid arthritis (RA). METHODS A search of the electronic databases Medline (PubMed), Embase and Cochrane was performed in July 2012 to identify trials and studies addressing tight control with treat-to-target reporting on (sustained) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Reumatologia clinica
دوره 9 2 شماره
صفحات -
تاریخ انتشار 2013